Just 1,000 Extra Steps a Day Lifts Mood in Adults with Heart Disease and Diabetes

A large new study from Lithuania suggests that one of the simplest interventions in medicine—walking a bit more each day—may deliver its most reliable benefits not to the bathroom scale but to the mind. In a three-month, smartphone-supported walking program involving 419 adults living with cardiovascular disease and/or type 2 diabetes, researchers found that participants added roughly 1,000 steps to their daily total, and that this modest increase was accompanied by measurable improvements in vigor, well-being, and happiness, along with a reduction in perceived stress. Body weight, body mass index, and body fat percentage also declined, but the authors are candid that these physical changes were small. The findings, published in BMC Public Health, arrive at a moment when clinicians and public health officials are searching for scalable, low-cost strategies to help the growing population of people living with cardiometabolic disease.

The study, led by Albertas Skurvydas of Klaipėda University and Daiva Majauskiene, together with colleagues at Vytautas Magnus University, UAB Walk15, the Lithuanian University of Health Sciences, and Vilnius University, was designed as a quasi-experimental intervention rather than a randomized controlled trial. All participants had established cardiometabolic conditions, the very population in which sedentary behavior is most common and most dangerous. For three months, their daily steps were objectively tracked using wearable devices connected to their smartphones, removing the recall bias and wishful thinking that plague self-reported physical activity data. Psychological, behavioral, functional, and body-composition outcomes were assessed before and after the intervention period, allowing the team to quantify how changes in walking volume related to changes in health markers across the same individuals.

The headline number is deceptively modest: approximately 1,000 additional steps per day. In effect-size terms, the researchers report a standardized change of dav = 0.41 for daily step count, a small-to-moderate shift that nonetheless proved meaningful across the cohort. What makes this figure notable is its context. Adults with cardiovascular disease or type 2 diabetes often face fatigue, pain, fear of exertion, and practical barriers that make ambitious exercise prescriptions unrealistic. A target that asks people to add roughly ten minutes of walking to their day, rather than demanding 10,000 steps or gym memberships, is the kind of intervention that can actually be adopted at population scale—and, crucially, monitored passively through hardware most people already carry in their pockets.

The psychological results were the study’s clearest signal. Vigor, the sense of energy and physical vitality captured by validated mood inventories, improved with an effect size of dav = 0.34, the largest psychological effect in the study and one that held up under the researchers’ conservative statistical corrections. General well-being improved modestly (dav = 0.17), as did self-reported happiness (dav = 0.15), while perceived stress declined (dav = −0.20). Anxiety also trended downward, but this change did not survive the Benjamini–Hochberg false discovery rate correction the team applied to guard against false positives arising from testing many outcomes simultaneously. That statistical discipline matters: in behavioral intervention research, where dozens of questionnaires can be administered, uncorrected analyses routinely manufacture effects that evaporate on replication.

Equally important is what the study did not find. After false discovery rate correction, no significant Gender × Time interactions emerged, meaning that women and men in the cohort showed broadly similar patterns of psychological and physical change. This absence of sex-specific divergence is practically useful, because it suggests a single, unified walking prescription may work comparably across sexes rather than requiring tailored targets. It also counters a persistent assumption in physical activity research that men and women respond differently to simple lifestyle interventions, at least at this modest dose of added movement.

The body-composition story is more sobering, and the authors do not oversell it. Body weight, BMI, and body fat percentage all decreased significantly over the three months, but every one of these effects was tiny, with standardized effect sizes no larger than |dav| = 0.06. Absolute lean mass and handgrip strength, a widely used proxy for overall muscle function and a predictor of mortality in clinical populations, showed no statistically significant change at all. In other words, adding 1,000 daily steps for twelve weeks nudged the scale in the right direction for the average participant, but nobody should expect walking alone at this volume to reshape body composition or preserve muscle mass in people with cardiometabolic disease. Resistance training and dietary strategies remain essential companions for those goals.

The regression analyses add a layer of mechanistic interest. Using multivariable linear regression with HC3 robust standard errors—a technique that guards against distorted significance estimates when residual variance is uneven across participants—the researchers found that the increase in daily step count was independently associated with greater improvement in vigor (β = 0.144, p = 0.003). This suggests that the energizing effect of walking is not merely a byproduct of weight loss or social contact but appears tied to the movement itself. Conversely, greater weight loss was associated primarily with higher baseline body weight (β = −0.247, p < 0.001), a statistical phenomenon familiar to any clinician: heavier individuals have more room to lose, and their absolute changes tend to be larger regardless of behavior change. Step count, by contrast, did not emerge as a strong independent predictor of weight loss, reinforcing the dissociation between the psychological and physical effects of the intervention.

Why would such a small increase in movement produce a noticeable lift in mood? Several physiological mechanisms are plausible. Walking increases blood flow, stimulates the release of endorphins and endocannabinoids, and modulates autonomic nervous system balance in ways associated with reduced stress reactivity. In people with type 2 diabetes, even light post-meal walking improves glycemic excursions, and smoother glucose curves are themselves linked to better mood and energy. There is also a behavioral feedback loop worth taking seriously: wearable devices make progress visible, and visible progress is intrinsically reinforcing. The smartphone platform used in this study turned an abstract health goal into a daily, quantifiable achievement, a design principle borrowed directly from the behavioral science of habit formation.

The study’s limitations deserve honest framing, and the authors acknowledge the most important one themselves. Because the design was quasi-experimental, with no randomized control group, causality cannot be established. People who joined a walking program may have been more motivated, healthier in unmeasured ways, or experiencing a favorable moment in their disease trajectory; the passage of three months alone, with seasonal change and novelty effects, could account for some of the observed improvements. The authors explicitly call for controlled studies to confirm causality and clinical significance. There is also the question of durability: three months is long enough to form habits but short enough that relapse remains a real risk once monitoring ends. Whether the psychological gains persist after the smartphone prompts stop is a question this study cannot answer.

Even with those caveats, the practical implications are compelling. Cardiometabolic disease—hypertension, coronary artery disease, type 2 diabetes, and their clustering as metabolic syndrome—remains the leading driver of death and disability worldwide, and the medications that manage it do nothing directly for the low-grade malaise, stress, and diminished vitality that patients routinely report. This study suggests that a nearly free intervention, delivered through devices that hundreds of millions of people already own, can move the needle on how those patients feel, even when it barely moves the needle on what they weigh. The trial is registered with ClinicalTrials.gov (NCT07674459), the analysis was preregistered in its essentials, and the statistical corrections were applied rigorously—hallmarks of a team trying to do behavioral science properly. For clinicians counseling patients who find exercise prescriptions intimidating, the message from Klaipėda is refreshingly modest: add about a thousand steps a day, watch your energy rise, and treat any change on the scale as a bonus rather than the goal. Sometimes the most viral idea in health science is also the oldest one—walk more, feel better—and now it comes with numbers attached.

Subject of Research: Effects of increased daily walking on psychological well-being and body composition in adults with cardiometabolic disease

Article Title: Increased daily walking is associated with changes in psychological well-being and small changes in body composition in adults with cardiometabolic disease

Article References: Skurvydas, A., Musvydaite-Vilciauske, V., Visinskis, V., Razbadauskas, A., Sarkauskiene, A., Majauskaite, J., Valanciene, D., & Majauskiene, D. (2026). Increased daily walking is associated with changes in psychological well-being and small changes in body composition in adults with cardiometabolic disease. BMC Public Health. https://doi.org/10.1186/s12889-026-29727-6

Image Credits: AI Generated

DOI: 10.1186/s12889-026-29727-6

Keywords: daily step count, walking intervention, cardiometabolic disease, psychological well-being, vigor, stress, body composition, wearable technology, digital health, type 2 diabetes, cardiovascular disease, BMC Public Health